| Primary |
| Chronic Obstructive Pulmonary Disease |
55.6% |
| Asthma |
33.3% |
| Blood Pressure |
11.1% |
|
| Malaise |
33.3% |
| Fatigue |
16.7% |
| Tremor |
16.7% |
| Upper Limb Fracture |
16.7% |
| Viith Nerve Paralysis |
16.7% |
|
| Secondary |
| Asthma |
36.6% |
| Chronic Obstructive Pulmonary Disease |
17.9% |
| Bronchitis |
10.3% |
| Hypertension |
7.7% |
| Emphysema |
6.6% |
| Hypothyroidism |
2.2% |
| Off Label Use |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Pneumonia |
1.8% |
| Bronchospasm |
1.5% |
| Intraocular Pressure Increased |
1.5% |
| Respiratory Distress |
1.5% |
| Rhinitis |
1.5% |
| Nasopharyngitis |
1.1% |
| Prophylaxis Of Neural Tube Defect |
1.1% |
| Tachycardia |
1.1% |
| Vaginal Infection |
1.1% |
| Bronchitis Chronic |
0.7% |
| Dyspnoea |
0.7% |
| Epigastric Discomfort |
0.7% |
|
| Respiratory Failure |
8.8% |
| Pneumonia |
7.0% |
| Sinusitis |
7.0% |
| Wrist Fracture |
7.0% |
| Wrong Technique In Drug Usage Process |
7.0% |
| Feeling Abnormal |
5.3% |
| General Physical Health Deterioration |
5.3% |
| Immune System Disorder |
5.3% |
| Respiratory Tract Infection |
5.3% |
| Respiratory Tract Infection Bacterial |
5.3% |
| Weight Decreased |
5.3% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Dyspnoea |
3.5% |
| Haemangioma Congenital |
3.5% |
| Pain In Extremity |
3.5% |
| Paraesthesia Oral |
3.5% |
| Reproductive Tract Disorder |
3.5% |
| Respiratory Arrest |
3.5% |
| Type 2 Diabetes Mellitus |
3.5% |
| Urinary Tract Infection |
3.5% |
|
| Concomitant |
| Asthma |
17.1% |
| Chronic Obstructive Pulmonary Disease |
12.0% |
| Product Used For Unknown Indication |
10.9% |
| Non-small Cell Lung Cancer |
8.6% |
| Hypertension |
8.0% |
| Cardiac Failure |
7.4% |
| Myocardial Ischaemia |
5.7% |
| Diabetes Mellitus |
3.4% |
| Drug Use For Unknown Indication |
3.4% |
| Bronchitis |
2.9% |
| Depression |
2.9% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Dyspnoea |
2.3% |
| Rhinitis |
2.3% |
| Thrombocytosis |
2.3% |
| Breast Cancer Metastatic |
1.7% |
| Bronchitis Acute |
1.7% |
| Off Label Use |
1.7% |
| Osteoporosis |
1.7% |
| Rheumatoid Arthritis |
1.7% |
|
| Rhabdomyolysis |
9.3% |
| Tachycardia |
9.3% |
| Abdominal Pain |
7.0% |
| Condition Aggravated |
7.0% |
| Influenza |
7.0% |
| Atrial Fibrillation |
4.7% |
| Fall |
4.7% |
| Gastrointestinal Disorder |
4.7% |
| Muscle Rigidity |
4.7% |
| Palpitations |
4.7% |
| Pneumonia |
4.7% |
| Respiratory Failure |
4.7% |
| Respiratory Tract Irritation |
4.7% |
| Sudden Death |
4.7% |
| Toxic Epidermal Necrolysis |
4.7% |
| Weight Increased |
4.7% |
| Anosmia |
2.3% |
| Asthma |
2.3% |
| Blood Bilirubin Increased |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
|
| Interacting |
| Bronchopulmonary Disease |
75.0% |
| Ankylosing Spondylitis |
25.0% |
|
| Respiratory Failure |
100.0% |
|
